1. Home
  2. CMPX vs VZLA Comparison

CMPX vs VZLA Comparison

Compare CMPX & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.94

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

VZLA

Vizsla Silver Corp.

N/A

Current Price

$3.53

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CMPX
VZLA
Founded
2014
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
927.5M
1.1B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
CMPX
VZLA
Price
$1.94
$3.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$15.83
$7.00
AVG Volume (30 Days)
7.9M
7.3M
Earning Date
05-06-2026
12-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$934.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$2.04
52 Week High
$6.88
$7.19

Technical Indicators

Market Signals
Indicator
CMPX
VZLA
Relative Strength Index (RSI) 19.32 47.17
Support Level N/A $3.23
Resistance Level $3.74 $3.54
Average True Range (ATR) 0.52 0.15
MACD -0.27 0.03
Stochastic Oscillator 1.91 42.17

Price Performance

Historical Comparison
CMPX
VZLA

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

Share on Social Networks: